Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Commercialization deals
Biotech
Novartis inks $150M deal for autoimmune molecular glue
In addition to the upfront cash, Monte Rosa can receive up to $2.1 billion in development, regulatory and sales milestones.
Darren Incorvaia
Oct 28, 2024 7:00am
Coya taps familiar friend Dr. Reddy's to commercialize ALS med
Dec 6, 2023 11:20am
Santhera offloads North American rights for DMD med to Catalyst
Jun 20, 2023 9:53am
Ascensia Diabetes Care launches Eversense's 6-month CGM system
Apr 4, 2022 10:45am
Capricor, Nippon ink $705M biobucks deal for phase 3 DMD therapy
Jan 25, 2022 5:00am
Cytokinetics, Royalty partner on heart failure drug for $450M
Jan 7, 2022 9:55am
